Article
Polymorphism in the retinoic acid metabolizing enzyme CYP26B1 and the development of Crohn's Disease.
PloS one - 1 Jan 2013
Fransén Karin, Franzén Petra, Magnuson Anders, Elmabsout Ali Ateia, Nyhlin Nils, Wickbom Anna, Curman Bengt, Törkvist Leif, D'Amato Mauro, Bohr Johan, Tysk Curt, Sirsjö Allan, Halfvarson Jonas
Abstract excerpt
Several studies suggest that Vitamin A may be involved in the pathogenesis of inflammatory bowel disease (IBD), but the mechanism is still unknown. Cytochrome P450 26 B1 (CYP26B1) is involved in the degradation of retinoic acid and the polymorphism rs2241057 has an elevated catabolic function of retinoic acid, why we hypothesized that the rs2241057 polymorphism may affect the risk of Crohn's disease (CD) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
